About: http://data.cimple.eu/news-article/44e84cc925c2c5c875b8367e5d6fd83ddec0ac0dfa5ee181a9b326c5

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/44e84cc925c2c5c875b8367e5d6fd83ddec0ac0dfa5ee181a9b326c5 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	The antimalarial drug hydroxychloroquine has shown mixed results against the coronavirus in early studies, but a new paper out of New York suggests combining it with the dietary supplement zinc sulfate could create a more effective treatment. The research by the NYU Grossman School of Medicine was posted on a medical preprint site on Monday, meaning it hasn't yet been peer reviewed. Records of about 900 COVID-19 patients were reviewed in the analysis, with roughly half given zinc sulfate along with hydroxychloroquine and the antibiotic azithromycin. The other half only received hydroxychloroquine and azithromycin. Those receiving the triple-drug combination had a 1.5 times greater likelihood of recovering enough to be discharged, and were 44 percent less likely to die, compared to the double-drug combination. It did not, however, change the average time patients spent in hospital (six days), the time they spent on the ventilator (five days), or the total amount of oxygen required. Senior investigator and infectious disease specialist Joseph Rahimian told AFP it was the first study to compare the two combinations. But he cautioned that a controlled experiment would be needed to prove the benefits beyond doubt. "The next logical step would be to do a prospective study to see if this holds up in people that you give zinc to, and then you watch and compare," he said. Hydroxychloroquine has been proposed as a treatment against the SARS-CoV-2 virus because it has antiviral properties that have been proven in lab settings, but not in people. It interferes with the virus' ability to enter the cells -- and also seems to block them from replicating once they are already inside. Zinc itself has antiviral properties and past research has suggested it may reduce the time people suffer from common colds. Rahimian said that it may be that when used to treat coronavirus patients, it is the zinc that does the heavy lifting and is the primary substance attacking the pathogen. Hydroxychloroquine, on the other hand, acts as an agent that transports the zinc into cells, increasing its efficacy, he suggested. ia/bgs
schema:headline	Zinc-hydroxychloroquine found effective in some COVID-19 patients: study
schema:mentions	Joseph Smith Zinc sulfate Preprint Antimalarial medication Oxygen therapy Azithromycin Dietary supplement Pathogen Agence France-Presse Infection Antiviral drug Antibiotic Ia (cuneiform) Hydroxychloroquine New York City Virus Coronavirus Severe acute respiratory syndrome coronavirus 2 Coronavirus disease 2019 Zinc deficiency New York University School of Medicine Scientific control
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2020-05-11 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	positive sentiment
http://data.cimple...readability_score	76 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness
http://data.cimple...entionsConspiracy	suppressed cures conspiracy theory

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 3 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software